![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 41169 |
FusionGeneSummary for USP53_SYNPO2 |
![]() |
Fusion gene information | Fusion gene name: USP53_SYNPO2 | Fusion gene ID: 41169 | Hgene | Tgene | Gene symbol | USP53 | SYNPO2 | Gene ID | 54532 | 171024 |
Gene name | ubiquitin specific peptidase 53 | synaptopodin 2 | |
Synonyms | - | - | |
Cytomap | 4q26 | 4q26 | |
Type of gene | protein-coding | protein-coding | |
Description | inactive ubiquitin carboxyl-terminal hydrolase 53inactive ubiquitin-specific peptidase 53ubiquitin specific protease 53ubiquitin specific proteinase 53 | synaptopodin-2genethonin-2myopodin | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q70EK8 | Q9UMS6 | |
Ensembl transtripts involved in fusion gene | ENST00000274030, ENST00000450251, ENST00000510737, | ENST00000307142, ENST00000448416, ENST00000429713, ENST00000434046, | |
Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 7 X 6 X 3=126 |
# samples | 4 | 8 | |
** MAII score | log2(4/18*10)=1.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(8/126*10)=-0.655351828612554 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: USP53 [Title/Abstract] AND SYNPO2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | OV | TCGA-24-2033-01A | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000274030 | ENST00000307142 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
5UTR-3CDS | ENST00000274030 | ENST00000448416 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
5UTR-3CDS | ENST00000274030 | ENST00000429713 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
5UTR-3CDS | ENST00000274030 | ENST00000434046 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
intron-3CDS | ENST00000450251 | ENST00000307142 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
intron-3CDS | ENST00000450251 | ENST00000448416 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
intron-3CDS | ENST00000450251 | ENST00000429713 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
intron-3CDS | ENST00000450251 | ENST00000434046 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
3UTR-3CDS | ENST00000510737 | ENST00000307142 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
3UTR-3CDS | ENST00000510737 | ENST00000448416 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
3UTR-3CDS | ENST00000510737 | ENST00000429713 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
3UTR-3CDS | ENST00000510737 | ENST00000434046 | USP53 | chr4 | 120138828 | + | SYNPO2 | chr4 | 119944585 | + |
Top |
FusionProtFeatures for USP53_SYNPO2 |
![]() |
Hgene | Tgene |
USP53 | SYNPO2 |
Tight junction-associated protein that is involved inthe survival of auditory hair cells and hearing. Maybe bymodulating the barrier properties and mechanical stability oftight junctions (By similarity). Has no peptidase activity(PubMed:14715245). {ECO:0000250|UniProtKB:P15975,ECO:0000269|PubMed:14715245}. | Has an actin-binding and actin-bundling activity. Caninduce the formation of F-actin networks in an isoform-specificmanner (PubMed:24005909, PubMed:23225103). At the sarcomeric Zlines is proposed to act as adapter protein that links nascentmyofibers to the sarcolemma via ZYX and may play a role in earlyassembly and stabilization of the Z lines. Involved inautophagosome formation. May play a role in chaperone-assistedselective autophagy (CASA) involved in Z lines maintenance instriated muscle under mechanical tension; may link the client-processing CASA chaperone machinery to a membrane-tethering andfusion complex providing autophagosome membranes (By similarity).Involved in regulation of cell migration (PubMed:22915763,PubMed:25883213). May be a tumor suppressor (PubMed:16885336).{ECO:0000250|UniProtKB:D4A702, ECO:0000250|UniProtKB:Q91YE8,ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:23225103,ECO:0000269|PubMed:24005909, ECO:0000269|PubMed:25883213,ECO:0000305|PubMed:16885336, ECO:0000305|PubMed:20554076}. Isoform 1: Involved in regulation of cell migration. Caninduce formation of thick, irregular actin bundles in the cellbody. {ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909}. Isoform 2: Involved in regulation of cell migration. Caninduce long, well-organized actin bundles frequently orientated inparallel along the long axis of the cell showing characteristicsof contractile ventral stress fibers.{ECO:0000269|PubMed:22915763, ECO:0000269|PubMed:24005909}. Isoform 3: Involved in regulation of cell migration. Caninduce an amorphous actin meshwork throughout the cell bodycontaining a mixture of long and short, randomly organized thickand thin actin bundles. {ECO:0000269|PubMed:22915763,ECO:0000269|PubMed:24005909}. Isoform 4: Can induce long, well-organized actin bundlesfrequently orientated in parallel along the long axis of the cellshowing characteristics of contractile ventral stress fibers.{ECO:0000269|PubMed:24005909}. Isoform 5: Involved in regulation of cell migration inpart dependent on the Rho-ROCK cascade; can promote formation ofnascent focal adhesions, actin bundles at the leading cell edgeand lamellipodia (PubMed:22915763, PubMed:25883213). Can induceformation of thick, irregular actin bundles in the cell body; theinduced actin network is associated with enhanced cell migrationin vitro. {ECO:0000269|PubMed:22915763,ECO:0000269|PubMed:24005909, ECO:0000269|PubMed:25883213}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for USP53_SYNPO2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for USP53_SYNPO2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
USP53 | TRAF2, ANXA2P2, ARG1, AZGP1, BLMH, CAT, CSTA, DSG1, FLNC, HCFC1, PPP2R1B, PSMA6, RPL26, TGM3, RAD50, CASP14, CPNE7, YAE1D1, KRT77, GRB2, DDB2, IREB2, PVRL2, DAB1, ZEB1, TRIM25 | SYNPO2 | YWHAG, YWHAZ, IPO13, CDK6, BAG3, HSPA8, SQSTM1, FLNA, VPS18, ATG16L1, MAP1LC3A, STX7, FLNC, ACTN2, NTRK1, RHOA, PLK4, POLK |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for USP53_SYNPO2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for USP53_SYNPO2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | SYNPO2 | C0677886 | Epithelial ovarian cancer | 1 | CTD_human |